wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38084363-8F2D8DB6-CF5D-4DAB-AF04-D2BB7569E459
Q38084363-8F2D8DB6-CF5D-4DAB-AF04-D2BB7569E459
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38084363-8F2D8DB6-CF5D-4DAB-AF04-D2BB7569E459
SGLT2 inhibition: a novel prospective strategy in treatment of diabetes mellitus.
P2860
Q38084363-8F2D8DB6-CF5D-4DAB-AF04-D2BB7569E459
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38084363-8F2D8DB6-CF5D-4DAB-AF04-D2BB7569E459
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7f9ca0c07505b7cae50b499fdd5842ca57b993f4
P2860
Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models.